Similarly, a clinical study reported that the correlation between reduced cerebrospinal fluid irisin levels and core Alzheimer’s disease biomarkers was more pronounced in women [20]. This evidence concerns the gene FNDC5 and early-onset autosomal dominant Alzheimer disease.